相关临床试验
0
0 进行中
药物批准
5
批准总数
监管机构
1
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
- SKYX Platforms Corp. closed a $25 million funding round from a fundamental institutional investor at $2.50 per share to support working capital and general corporate purposes. - The company announced a collaboration with NVIDIA's AI Ecosystem Connect Program to integrate AI capabilities into existing and future smart home projects. - SKYX launched its patented SKYFAN and Turbo Heater products at major U.S. retailers including Home Depot, Target, Walmart, and Lowe's, with revenues increasing for seven consecutive quarters. - The company expects to deploy over 1 million units of its plug-and-play technologies across upcoming smart home and smart city projects in North Carolina, Texas, Florida, Saudi Arabia, and Egypt.
- TempraMed Technologies has launched VIVI Cap Smart, the world's first platform that combines temperature protection with digital tracking for insulin and GLP-1 pens. - The device integrates proprietary space-grade thermal insulation technology with digital health functionality, enabling automatic injection timing tracking and medication logging through a connected mobile application. - This launch represents TempraMed's strategic transition toward a comprehensive patient platform that combines physical device innovation with digital tools for chronic disease management. - The company has already achieved significant commercial traction with over 120,000 devices sold globally and distribution through major retailers and healthcare organizations including Maccabi Healthcare Services.
